Literature DB >> 29850869

Sdha+/- Rats Display Minimal Muscle Pathology Without Significant Behavioral or Biochemical Abnormalities.

Emily M Siebers1,2, Melinda J Choi1,2, Jennifer A Tinklenberg1,2, Margaret J Beatka1,2, Samuel Ayres1,2, Hui Meng1,2, Daniel C Helbling1,2, Akiko Takizawa3,4, Brian Bennett5, Alexander M Garces3, Luiz-Gabriel Dias Duarte Machado5, David Dimmock6, Melinda R Dwinell3,4, Aron M Geurts5,4,7, Michael W Lawlor1,2.   

Abstract

Mitochondrial diseases (MDs) result from alteration of the mitochondrial respiratory chain (MRC) function. Despite the prevalence of MDs in the population, the paucity of animal models available limits the understanding of these disorders. Mutations in SDHA, a gene that codes for the alpha subunit of succinate dehydrogenase (SDH), can cause some forms of MD. SDHA is a crucial contributor to MRC function. In order to expand the range of MD animal models available, we attempted to generate a Sdha knockout rat. Since homozygous Sdha-/- rats could neither be identified in newborn litters, nor as early as embryonic day 14, we evaluated wild-type (WT) and heterozygous Sdha+/- genotypes. No differences in behavioral, biochemical, or molecular evaluations were observed between WT and Sdha+/- rats at 6 weeks or 6 months of age. However, 30% of Sdha+/- rats displayed mild muscle fiber atrophy with rare fibers negative for cytochrome oxidase and SDH on histochemical staining. Collectively, our data provide additional evidence that modeling SDH mutations in rodents may be challenging due to animal viability, and heterozygous rats are insufficiently symptomatic at a phenotypic and molecular level to be of significant use in the study of SDH deficiency.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29850869      PMCID: PMC6044411          DOI: 10.1093/jnen/nly042

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.148


  27 in total

1.  Genome-wide scanning with SSLPs in the rat.

Authors:  Carol Moreno; Kathleen Kennedy; Jaime Wendt Andrae; Howard J Jacob
Journal:  Methods Mol Med       Date:  2005

2.  Treatment with ActRIIB-mFc Produces Myofiber Growth and Improves Lifespan in the Acta1 H40Y Murine Model of Nemaline Myopathy.

Authors:  Jennifer Tinklenberg; Hui Meng; Lin Yang; Fujun Liu; Raymond G Hoffmann; Mahua Dasgupta; Kenneth P Allen; Alan H Beggs; Edna C Hardeman; R Scott Pearsall; Robert H Fitts; Michael W Lawlor
Journal:  Am J Pathol       Date:  2016-04-18       Impact factor: 4.307

Review 3.  Presentation and Diagnostic Evaluation of Mitochondrial Disease.

Authors:  David P Dimmock; Michael W Lawlor
Journal:  Pediatr Clin North Am       Date:  2017-02       Impact factor: 3.278

Review 4.  Revisiting the TCA cycle: signaling to tumor formation.

Authors:  Nuno Raimundo; Bora E Baysal; Gerald S Shadel
Journal:  Trends Mol Med       Date:  2011-07-20       Impact factor: 11.951

Review 5.  Mitochondrial diseases in man and mouse.

Authors:  D C Wallace
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

6.  Generation of gene-specific mutated rats using zinc-finger nucleases.

Authors:  Aron M Geurts; Gregory J Cost; Séverine Rémy; Xiaoxia Cui; Laurent Tesson; Claire Usal; Séverine Ménoret; Howard J Jacob; Ignacio Anegon; Roland Buelow
Journal:  Methods Mol Biol       Date:  2010

Review 7.  Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning.

Authors:  Stefan Dröse
Journal:  Biochim Biophys Acta       Date:  2013-01-16

8.  Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.

Authors:  Fernando Scaglia; Jeffrey A Towbin; William J Craigen; John W Belmont; E O'Brian Smith; Stephen R Neish; Stephanie M Ware; Jill V Hunter; Susan D Fernbach; Georgirene D Vladutiu; Lee-Jun C Wong; Hannes Vogel
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

9.  Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice.

Authors:  Michael W Lawlor; Marissa G Viola; Hui Meng; Rachel V Edelstein; Fujun Liu; Ke Yan; Elizabeth J Luna; Alexandra Lerch-Gaggl; Raymond G Hoffmann; Christopher R Pierson; Anna Buj-Bello; Jennifer L Lachey; Scott Pearsall; Lin Yang; Cecilia J Hillard; Alan H Beggs
Journal:  Am J Pathol       Date:  2014-04-13       Impact factor: 4.307

10.  SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.

Authors:  Ruth T Casey; David B Ascher; Eleanor Rattenberry; Louise Izatt; Katrina A Andrews; Helen L Simpson; Benjamen Challis; Soo-Mi Park; Venkata R Bulusu; Fiona Lalloo; Douglas E V Pires; Hannah West; Graeme R Clark; Philip S Smith; James Whitworth; Thomas G Papathomas; Phillipe Taniere; Rosina Savisaar; Laurence D Hurst; Emma R Woodward; Eamonn R Maher
Journal:  Mol Genet Genomic Med       Date:  2017-03-02       Impact factor: 2.183

View more
  1 in total

1.  Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies.

Authors:  Balaraman Kalyanaraman; Gang Cheng; Jacek Zielonka; Brian Bennett
Journal:  Cell Biochem Biophys       Date:  2018-09-26       Impact factor: 2.194

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.